Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a new version of the page in the content management system.
    Difference
    0.0%
    Check dated 2026-05-14T23:23:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A revision tag on the page was updated from v3.5.2 to v3.5.3, indicating a system update; study content and displayed information remain unchanged.
    Difference
    0.0%
    Check dated 2026-04-30T18:07:01.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:53:40.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and a new 'resources' section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T06:17:08.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This is a minor metadata update that does not affect study content or results.
    Difference
    0.0%
    Check dated 2026-03-18T20:29:27.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added in the page header, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:49:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.